AAV	Adeno-associated viral vector
Ab	Antibody
ADA	Anti-drug antibodies
AMD	Age-related macular degeneration
ANG2	Angiopoietin-2
C	Carboxy-terminus
CDR	Complementarity-determining region
CH	Constant domain of the heavy chain
CL	Constant domain of the light chain
CNAR	Constant domain of IgNAR
CNV	Choroidal neovascularization
EAU	Experimental autoimmune uveitis
ERG	Electroretinography
Fab	Fragment antigen-binding
FDA	The U.S. Food and Drug Administration
Fc	Fragment crystallizable
FR	Framework region
hcAb	Heavy-chain-only antibody
HV	Hypervariable region
ICOSL	Induced costimulatory ligand
IgG	Immunoglobulin G
IgNAR	Immunoglobulin new antigen receptor
IL	Interleukin
IL-1β	Interleukin-1 beta
IL-6	Interleukin-6
IL-8	Interleukin-8
i.p.	Intraperitoneal
LOX-1	Lectin-like oxidized low-density lipoprotein receptor-1
LV	Lentiviral vector
mAb	Monoclonal antibody
nAMD	Neovascular age-related macular degeneration
NHP	Non-human primate
OCT	Optical coherence tomography
OIR	Oxygen-induced retinopathy
RPE	Retinal pigment epithelium
scFab	Single-chain Fab
scFv	Single-chain variable fragment
sdAb	Single-domain antibody
STAT3	Signal transducer and activator of transcription 3
TCE	T-cell epitope
TNFα	Tumor necrosis factor alpha
VEGF	Vascular endothelial growth factor
VEGFA	Vascular endothelial growth factor A
VEGFR	Vascular endothelial growth factor receptor
VH	Variable domain of the heavy chain
VHH	Variable heavy domain of heavy chain
VL	Variable domain of the light chain
VNAR	Variable new antigen receptor